/term/roe-adj/FRA:NZW Molecular Templates (FRA:NZW) ROE % Adjusted to Book Value
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Templates Inc (FRA:NZW) » Definitions » ROE % Adjusted to Book Value

Molecular Templates (FRA:NZW) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Molecular Templates ROE % Adjusted to Book Value?

Molecular Templates's ROE % for the quarter that ended in Mar. 2024 was 45.43%. Molecular Templates's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Molecular Templates's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.


Molecular Templates ROE % Adjusted to Book Value Historical Data

The historical data trend for Molecular Templates's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Templates ROE % Adjusted to Book Value Chart

Molecular Templates Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.29 -16.41 -48.40 - -

Molecular Templates Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Negative Equity - - - -

Competitive Comparison of Molecular Templates's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Molecular Templates's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molecular Templates's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Templates's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Molecular Templates's ROE % Adjusted to Book Value falls into.



Molecular Templates ROE % Adjusted to Book Value Calculation

Molecular Templates's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Molecular Templates's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=45.43% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molecular Templates ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Molecular Templates's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecular Templates (FRA:NZW) Business Description

Traded in Other Exchanges
Address
9301 Amberglen Boulevard, Suite 100, Austin, TX, USA, 78729
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer.

Molecular Templates (FRA:NZW) Headlines

No Headlines